2022-05-11T04:06:32-05:00 2021-06-30 366055558 GRANT THORNTON LLP 75 STATE ST 13TH FLOOR BOSTON MA 02109 990 2020-07-01 042104230 FORSYTH DENTAL INFIRMARY FOR CHILDREN FORS 6172625200 245 FIRST STREET CAMBRIDGE MA 02142 MICHAEL ROSS INTERIM CFO & TREASURER 6172625200 2022-05-11 1 MICHAEL ROSS XXX-XX-XXXX ERIN COUTURE P01390592 6177237900 0 AAL1 IAL1 2020 2022-09-23 18:48:47Z THE FORSYTH INSTITUTE WENYUAN SHI 245 FIRST STREET CAMBRIDGE MA 02142 16645150 0 X WWW.FORSYTH.ORG X 1910 MA TO IMPROVE ORAL AND OVERALL HEALTH THROUGH COMBINATION OF INNOVATIVE (CONTINUED ON SCHEDULE O) RESEARCH AND COMMUNITY OUTREACH BY ACCELERATING THE DELIVERY OF WELLNESS SOLUTIONS LOCALLY AND GLOBALLY. 18 17 126 74 977504 0 10237601 10873715 3594578 3826542 1298511 1886876 31546 57962 15162236 16645095 1156844 1045896 0 0 12452850 11608601 0 3063 200736 10972924 9997209 24582618 22654769 -9420382 -6009674 46427599 49095156 9531864 10226899 36895735 38868257 X FOR MORE THAN 100 YEARS, FORSYTH HAS BEEN A LEADER IN THE FIELDS OF DENTAL RESEARCH AND PEDIATRIC DENTAL CARE. TODAY, WE ARE GROUNDED IN A 3-PILLARED STRATEGIC PLAN FOCUSED ON (SCHEDULE O) 0 0 16418599 1045896 3826542 THE FORSYTH INSTITUTE IS THE ONLY INDEPENDENT RESEARCH INSTITUTE IN THE UNITED STATES FOCUSING ON THE CONNECTIONS BETWEEN ORAL HEALTH AND OVERALL WELLNESS. 16418599 1 1 0 1 0 0 0 0 0 1 1 1 0 0 1 1 0 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 37 0 1 126 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 18 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 MA X X MICHAEL ROSS 6178928317 245 FIRST STREET CAMBRIDGE MA 02142 DR WENYUAN SHI CEO & CHIEF SCIENTIFIC OFFICER 45.00 0.00 X X 424004 0 34806 MS ELYSE D CHERRY CHAIR 4.00 0.00 X X 0 0 0 DR DAVID W ELLIS VICE CHAIR 1.00 0.00 X X 0 0 0 MR RICHARD ANDERS DIRECTOR 1.00 0.00 X 0 0 0 MS JANICE BOURQUE DIRECTOR 1.00 0.00 X 0 0 0 MS PAMELA CARRINGTON SCOTT DIRECTOR 1.00 0.00 X 0 0 0 MS PAMELA N CZEKANSKI DIRECTOR 1.00 0.00 X 0 0 0 MS CATHERINE D'AMATO DIRECTOR 1.00 0.00 X 0 0 0 DR BRUCE DONOFF DIRECTOR 1.00 0.00 X 0 0 0 MR DAI FENG DIRECTOR 1.00 0.00 X 0 0 0 MR MICHAEL GREELEY DIRECTOR 1.00 0.00 X 0 0 0 MS ROSALEE HERMENS DIRECTOR (THRU 10/2020) 1.00 0.00 X 0 0 0 MS KARLA L JARVIS DIRECTOR 1.00 0.00 X 0 0 0 MS JANET KELLY DIRECTOR (THRU 10/2020) 1.00 0.00 X 0 0 0 MR RAJI KOHLI DIRECTOR 1.00 0.00 X 0 0 0 DR BRUCE LIEBERTHAL DIRECTOR 1.00 0.00 X 0 0 0 MR MICHAEL MONOPOLI DIRECTOR 1.00 0.00 X 0 0 0 MR PETER NESSEN DIRECTOR 1.00 0.00 X 0 0 0 MR JOHN M PLUKAS DIRECTOR (THRU 10/2020) 1.00 0.00 X 0 0 0 MR WALTER M PRESSEY DIRECTOR 1.00 0.00 X 0 0 0 MS ROBYN REDFIELD DIRECTOR 1.00 0.00 X 0 0 0 MS WANDA CORDOVA CFO & TREASURER 45.00 0.00 X 234251 0 18391 MS CARLINE DUROCHER GENERAL LEGAL COUNSEL & SEC 45.00 0.00 X 237083 0 48793 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 45.00 0.00 X 308378 0 23432 DR FLOYD DEWHIRST SENIOR SCIENTIST 45.00 0.00 X 220067 0 47594 DR PRAMOD M SOPARKAR SENIOR SCIENTIST 45.00 0.00 X 220572 0 35308 DR IBRAHIM KANTARCI SENIOR SCIENTIST 45.00 0.00 X 179256 0 23512 MS PAULA LAPALME CHIEF ADMINISTRATION OFFICER 45.00 0.00 X 190138 0 16928 DR XUESONG HE ASSOCIATE SCIENTIST 45.00 0.00 X 189250 0 12163 2202999 0 260927 25 0 1 0 AQUEDUCT TECHNOLOGIES INC 333 WYMAN STREET SUITE 300 WALTHAM MA 02451 IT MANAGED SERVICES 358000 FOLEY HOAG LLP SEAPORT WEST 155 SEAPORT BLVD BOSTON MA 02210 LEGAL 123540 2 79189 9527534 1266992 10873715 FESC RESEARCH CENTER 541700 1883467 1883467 DENTAL SERVICES 621400 990798 13294 977504 RESEARCH 541700 952277 952277 3826542 541542 541542 1345334 0 1345334 1345334 1345334 0 79189 55 -55 -55 MISCELLANEOUS INCOME 900099 58017 58017 58017 16645095 2849038 977504 1944838 934465 934465 111431 111431 1330153 221144 1017697 91312 7676938 5322570 2318690 35678 376104 251182 118812 6110 1657080 996597 637431 23052 568326 348785 211388 8153 410888 159105 251783 102572 102572 15990 13902 2088 3063 3063 144762 144762 472568 171856 300712 11409 11409 351331 40972 298870 11489 4845520 4667485 170998 7037 46543 43368 3175 15288 5329 6619 3340 1896661 1860897 34350 1414 228192 220500 7388 304 SUPPLIES 800422 736550 61441 2431 OTHER EXPENSES 655063 312461 338424 4178 22654769 16418599 6035434 200736 1234332 1351700 300000 3064974 2371914 224790 332846 29970545 24424707 7384897 5545838 29959133 34287769 4259473 5205089 46427599 49095156 1915539 2488936 441053 414426 2814900 3888255 4360372 3435282 9531864 10226899 X 36853234 38854598 42501 13659 36895735 38868257 46427599 49095156 -6009674 7982196 0 X 0 1 X 1 1 1 X 16616306 11497146 13809241 10237652 10873715 63034060 2190176 2920350 3366338 2928986 2849038 14254888 18806482 14417496 17175579 13166638 13722753 77288948 37585 32050 10500 41500 20000 141635 746234 1558289 1536558 1929134 2149315 7919530 783819 1590339 1547058 1970634 2169315 8061165 69227783 661633 1063100 2052920 634383 541542 4953578 661633 1063100 2052920 634383 541542 4953578 184461 493402 302674 114557 58017 1153111 19652576 15973998 19531173 13915578 14322312 83395637 0.83010 0.86340 0.05940 0.05850 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2016 AMOUNT: $ 94,629. 2017 AMOUNT: $ 108,090. 2018 AMOUNT: $ 187,657. 2019 AMOUNT: $ 74,557. 2020 AMOUNT: $ 58,017. EVENT INCOME NET OF DONATIONS - 2016 AMOUNT: $ 89,832. 2017 AMOUNT: $ 60,290. 2018 AMOUNT: $ 115,017. 2019 AMOUNT: $ 40,000. 2020 AMOUNT: $ 0. INSURANCE CLAIM PAYMENT - 2016 AMOUNT: $ 0. 2017 AMOUNT: $ 325,022. 2018 AMOUNT: $ 0. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 15990 15990 22494017 22510007 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 68133 68496 68805 15990 221424 250000 250000 250000 250000 1000000 1500000 LOBBYING ACTIVITY: EXPENSES INCLUDE A CONTRACT WITH A LOBBYING FIRM FOR ASSISTANCE WITH STATE GRANT LOBBYING. ADDITIONALLY, FORSYTH BELONGS TO MEMBERSHIP ORGANIZATIONS WHICH ENGAGE IN LOBBYING ACTIVITIES. A PORTION OF THE DUES PAID ARE SPECIFICALLY IDENTIFIED AS LOBBYING EXPENSES. 34218606 9667919 4393667 39492858 39661387 1032607 6475388 34218606 44278955 2371539 1341452 8330559 39661387 49276967 4245291 9243303 44278955 50258923 5209122 6191078 49276967 1.00000 0 0 16774746 11923809 4850937 11475149 11008372 466777 1720650 1492526 228124 5545838 PRIVATE EQUITY INVESTMENTS 5205089 F 5205089 DEFERRED RENT 3435282 3435282 X 24482529 7982196 7982196 16500333 144762 144762 16645095 22510007 0 22510007 144762 144762 22654769 PART V, LINE 4: INTENDED USES OF ENDOWMENT FUNDS TO SUPPORT THE CHARITABLE MISSION OF THE FORSYTH DENTAL INFIRMARY FOR CHILDREN. PART X, LINE 2: ASC 740 FOOTNOTE THE INSTITUTE (AND FORSYTH INTERNATIONAL) ARE ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, AS AMENDED (THE "CODE"), AND ARE GENERALLY EXEMPT FROM INCOME TAXES PURSUANT TO SECTION 501(A) OF THE CODE. THE INSTITUTE TO IDENTIFY UNCERTAIN TAX POSITIONS AND HAS DETERMINED THAT NO SUCH POSITIONS EXIST THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 97990 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 13441 0 0 0 0 0 0 111431 0 111431 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 97990 CHECK MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 13441 CHECK 2 0 0 0 0 0 1 PART I, LINE 2: THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. PART III ACCOUNTING METHOD: PART I, LINE 3, COLUMN (F): THE INSTITUTE USES THE ACCRUAL METHOD OF ACCOUNTING. AN EVENING WITH FORSYTH INSTITUTE 79189 79189 55 79189 79189 55 55 -55 SCHEDULE G, PART II: DURING THE FISCAL YEAR THE INSTITUTE HELD A VIRTUAL EVENT AS A RESULT NO REVENUE AND MINIMAL EXPENSES WERE INCURRED IN CONNECTION WITH THE EVENT. 1 PRESIDENT & FELLOWS OF HARVARD COLLEGE 677 HUNTINGTON AVE BOSTON MA 02115 042103580 501(C)(3) 9854 PROGRAM SUPPORT THE JACKSON LABORATORY 610 MAIN ST BAR HARBOR ME 04609 010211513 501(C)(3) 54733 PROGRAM SUPPORT MARINE BIOLOGICAL LABORATORY 7 MBL ST WOODS HOLE MA 02543 042104690 501(C)(3) 142176 PROGRAM SUPPORT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVENUE NE SEATTLE WA 98195 916001537 GOV'T 446217 PROGRAM SUPPORT YALE UNIVERSITY 25 SCIENCE PARK 3RD FL NEW HAVEN CT 06508 060646973 501(C)(3) 85614 PROGRAM SUPPORT BRIGHAM & WOMEN'S HOSPITAL 77 LOUIS PASTER AVE BOSTON MA 02115 042312909 501(C)(3) 55753 PROGRAM SUPPORT UNIVERSITY OF FLORIDA 207 GRINTER HALL PO BOX 115500 GAINESVILLE FL 32611 596002052 501(C)(3) 112376 PROGRAM SUPPORT THE RESEARCH FOUNDATION UNIVERSITY OF BUFFALO 206 CROFTS HALL BUFFALO NY 14260 160865182 501(C)(3) 26037 PROGRAM SUPPORT 8 PART I, LINE 2: ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANTS IN THE U.S. THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. X X X X 0 0 0 0 0 0 0 1 0 DR WENYUAN SHI CEO & CHIEF SCIENTIFIC OFFICER 420650 0 0 0 3354 0 25365 0 9441 0 458810 0 0 0 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 302304 0 0 0 6074 0 22252 0 1180 0 331810 0 0 0 MS CARLINE DUROCHER GENERAL LEGAL COUNSEL & SEC 210636 0 25000 0 1447 0 18384 0 30409 0 285876 0 0 0 DR FLOYD DEWHIRST SENIOR SCIENTIST 214718 0 0 0 5349 0 17185 0 30409 0 267661 0 0 0 DR PRAMOD M SOPARKAR SENIOR SCIENTIST 210981 0 0 0 9591 0 16643 0 18665 0 255880 0 0 0 MS WANDA CORDOVA CFO & TREASURER 232700 0 0 0 1551 0 18391 0 0 0 252642 0 0 0 MS PAULA LAPALME CHIEF ADMINISTRATION OFFICER 184326 0 0 0 5812 0 7487 0 9441 0 207066 0 0 0 DR IBRAHIM KANTARCI SENIOR SCIENTIST 178387 0 0 0 869 0 14071 0 9441 0 202768 0 0 0 DR XUESONG HE ASSOCIATE SCIENTIST 188687 0 0 0 563 0 12163 0 0 0 201413 0 0 0 PART I, LINE 7 NON-FIXED PAYMENTS ON AN ANNUAL BASIS, ANY BONUS AWARDED TO THE CEO IS SUBJECT TO REVIEW AND APPROVAL BY THE BOARD OF DIRECTORS PRIOR TO PAYMENT. BONUS PAYMENTS TO OTHER KEY EMPLOYEES OR HIGHEST COMPENSATED EMPLOYEES ARE SUBJECT TO REVIEW AND APPROVAL BY THE CEO AND CFO. BONUSES ARE BASED ON INDIVIDUAL PERFORMANCE OR AS AGREED TO IN THE EMPLOYMENT AGREEMENT AND ANY AMOUNTS AWARDED ARE REPORTED ON SCHEDULE J, PART II, COLUMN (B)(II). MISSION STATEMENT (CONTINUED): FORM 990, PART III, LINE 1 BIOLOGICAL RESEARCH, CLINICAL SERVICE AND PUBLIC HEALTH OUTREACH, AND TECHNOLOGICAL INNOVATION. PILLAR 1: FORSYTH HAS A LONG LEGACY OF CHANGING THE ORAL HEALTH LANDSCAPE THROUGH DENTAL RESEARCH, DENTAL CLINICAL TRIALS, AND TRAINING. FOR DECADES, FORSYTH HAS BEEN A TOP-TIER INSTITUTION IN NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH FUNDING. OUR SCIENTISTS HAVE CONTRIBUTED TO THE HIGHEST IMPACT PUBLICATIONS IN THE ORAL HEALTH FIELD. PILLAR 2: THE FORSYTH INSTITUTE IS COMMITTED TO IMPROVING PUBLIC HEALTH IN THE COMMUNITIES WE SERVE. SINCE ITS INCEPTION IN 1910 AS A DENTAL INFIRMARY FOR CHILDREN, FORSYTH HAS ESTABLISHED ITSELF AS A PIONEER IN PEDIATRIC DENTISTRY, TREATING HUNDREDS OF THOUSANDS OF CHILDREN IN NEED ACROSS MASSACHUSETTS. FORSYTH CONTINUES TO CARRY OUT OUR FOUNDING MISSION PROVIDING ORAL HEALTH CARE THROUGH MOBILE, PRIVATE PRACTICE, AND GLOBAL PROGRAMS. IN 2001, FORSYTHKIDS BEGAN USING VANS TO DELIVER PREVENTIVE DENTAL CARE TO CHILDREN OF ALL AGES AT SCHOOLS, DAYCARES, SUMMER CAMPS, AND COMMUNITY CENTERS ACROSS MASSACHUSETTS. THE PROGRAM HAS PROVIDED CARE TO TENS OF THOUSANDS OF CHILDREN SINCE ITS INCEPTION. PILLAR 3: THE FORSYTH INSTITUTE IS UNIQUELY SUITED TO LEAD THE DEVELOPMENT OF NOVEL ORAL HEALTH TECHNOLOGIES. OUR ENTREPRENEURIAL SPIRIT ENCOURAGES RESEARCHERS TO BRING THEIR EXPERTISE TO THE COMMERCIAL MARKETPLACE, AND OUR CLINICAL TEAM IS EXPERIENCED IN PARTNERING WITH INDUSTRY TO TEST NEW TREATMENTS AND PRODUCTS. FORSYTH'S CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH OFFERS A HIGHLY SKILLED AND EXPERIENCED TEAM OF ADMINISTRATIVE STAFF, DENTAL PROFESSIONALS, LABORATORY TECHNICIANS, AND SUBJECT RECRUITMENT SPECIALISTS TO MEET EVERY NEED OF A RESEARCH PROJECT OR CLINICAL TRIAL. AS AN INDEPENDENT RESEARCH INSTITUTE, FORSYTH HAS THE FREEDOM TO FOLLOW OUR SCIENCE WHEREVER IT LEADS AND TO COLLABORATE WITH A BROAD SPECTRUM OF STAKEHOLDERS. THE INSTITUTE IS LOCATED IN KENDALL SQUARE, CAMBRIDGE, AN EPICENTER OF BIOTECHNOLOGY WITH ONE OF THE HIGHEST DENSITIES OF BIOMEDICAL RESEARCHERS IN THE WORLD. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE RETURN WAS PREPARED BY TAX ADVISORS FROM A NATIONAL ACCOUNTING FIRM WITH INFORMATION PROVIDED BY MANAGEMENT. THE DRAFT FORM 990 IS REVIEWED BY THE CEO, CFO, AND THE AUDIT, RISK & COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS. IT IS THEN DISTRIBUTED TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT FORSYTH'S CONFLICT OF INTEREST POLICY APPLIES TO FORSYTH'S BOARD MEMBERS, OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES AND WAS ESTABLISHED TO PROTECT THE INTEREST OF THE INSTITUTE - THE DESIGN, CONDUCT, OR REPORTING OF OPERATIONS OR RESEARCH. CONSISTENT WITH THE POLICY, OFFICERS, ADMINISTRATORS, RESEARCH STAFF EMPLOYEES AND BOARD MEMBERS ARE REQUIRED TO COMPLETE AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM. TO ACCOMPLISH THIS OBJECTIVE, THIS POLICY ESTABLISHES A DISCLOSURE SYSTEM WHEREBY POTENTIAL CONFLICT SITUATIONS WILL BE IDENTIFIED, REVIEWED AND ADDRESSED. FORSYTH OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES - FORSYTH'S SECRETARY/GENERAL COUNSEL IS THE INSTITUTIONAL OFFICIAL WHO IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS WHEN THE EMPLOYEES ARE FIRST HIRED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE INSTITUTIONAL OFFICIAL, IN CONSULTATION WITH FORSYTH'S CONFLICT OF INTEREST COMMITTEE. FORSYTH BOARD MEMBERS - FORSYTH'S SECRETARY/GENERAL COUNSEL IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS FROM BOARD MEMBERS AT THE TIME THEY ARE APPOINTED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE SECRETARY IN CONSULTATION WITH THE CHAIRMAN OF FORSYTH'S BOARD OF DIRECTORS. AS A VOTING BOARD MEMBER, THE CEO DOES NOT VOTE ON AND IS RECUSED WHEN A CONFLICT OF INTEREST ARISES. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION CEO COMPENSATION IS REVIEWED AND APPROVED ANNUALLY BY THE EXECUTIVE COMMITTEE OF THE INDEPENDENT BOARD OF DIRECTORS. COMPARABLE COMPENSATION DATA AND FORM 990 DATA FROM OTHER ORGANIZATIONS ARE UTILIZED FOR THE REVIEW OF CEO COMPENSATION. THE CEO REVIEWS AND APPROVES COMPENSATION FOR THE EXECUTIVE MANAGEMENT, USING MARKET SURVEYS AND FORM 990 DATA FOR OTHER SIMILAR ORGANIZATIONS. THESE DECISIONS ARE REVIEWED BY THE BOARD OF DIRECTORS. ANNUALLY, FORSYTH PARTICIPATES IN A COMPENSATION SURVEY THAT INCLUDES COMPARATIVE DATA OF SIMILAR ORGANIZATIONS. THESE ANALYSES ARE UTILIZED IN THE REVIEW OF THE CEO AND EXECUTIVE MANAGEMENT'S COMPENSATION. BOTH THE DELIBERATION AND DECISION PROCESS FOR DETERMINING COMPENSATION OF THE CEO AND EXECUTIVE MANAGEMENT IS CONTEMPORANEOUSLY DOCUMENTED. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE FORSYTH INSTITUTE MAKES ITS GOVERNING DOCUMENTS, WRITTEN POLICIES AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. THESE ITEMS ARE AVAILABLE UPON REQUEST. GENERAL STATEMENT REGARDING THE COVID-19 PANDEMIC: THE OUTBREAK OF COVID-19 HAS CAUSED DISRUPTION IN OPERATIONS OF BUSINESSES DOMESTICALLY AND GLOBALLY. IN RESPONSE, THE INSTITUTE IMPLEMENTED COST SAVINGS AND OTHER MEASURES TO REDUCE OPERATING EXPENSES AND ENSURE ADEQUATE LIQUIDITY. DUE TO THE UNCERTAINTY OF THE CONTINUED SPREAD OF THE VIRUS AND ECONOMIC OUTLOOK, THERE MAY BE SHORT-TERM AND LONG-TERM IMPLICATIONS FOR OPERATIONS OF THE INSTITUTE. FORSYTH INNOVATION LLC 245 FIRST STREET CAMBRIDGE MA 02142 TECH DEV DE 0 0 FORSYTH FORSYTH INTERNATIONAL INC 245 FIRST STREET CAMBRIDGE MA 02142 043443294 DENTAL CARE MA 501(C)(3) LINE 9 FORSYTH 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0